The Biotech Growth Trust PLC (LON:BIOG) Insider Hamish Baillie Purchases 1,200 Shares

The Biotech Growth Trust PLC (LON:BIOG) insider Hamish Baillie acquired 1,200 shares of the company’s stock in a transaction on Thursday, December 19th. The shares were acquired at an average price of GBX 856 ($10.76) per share, for a total transaction of £10,272 ($12,909.39).

Hamish Baillie also recently made the following trade(s):

• On Wednesday, November 27th, Hamish Baillie bought 3,000 shares of The Biotech Growth Trust stock. The stock was bought at an average price of GBX 931 ($11.70) per share, for a total transaction of £27,930 ($35,101.17).

The Biotech Growth Trust Price Performance

Shares of BIOG opened at GBX 868 ($10.91) on Friday. The stock has a 50 day moving average of GBX 970.52 and a 200-day moving average of GBX 995.11. The Biotech Growth Trust PLC has a 52 week low of GBX 840.94 ($10.57) and a 52 week high of GBX 1,068.36 ($13.43). The firm has a market cap of £278.89 million, a price-to-earnings ratio of 419.32 and a beta of 0.50. The company has a current ratio of 0.33, a quick ratio of 0.00 and a debt-to-equity ratio of 13.03.

The Biotech Growth Trust Company Profile

The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations.